Loading people...
Craig Cooper is an Investment Director at Serpentine Ventures in Zurich, Switzerland, where he leads the firm's Diabetes Venture Fund. Over a 25-year international career in venture capital and entrepreneurship, he has held senior executive leadership positions across Europe, Asia, and the Americas. Cooper previously co-founded the telecommunications brand Boost Mobile USA and later served as a Managing Director at Softbank Capital. Transitioning into the life sciences sector, he directed the investment arm of the AO Foundation to fund disruptive global healthcare innovations and mentored numerous early-stage health and technology startups. He holds dual degrees in Law and Economics and has extensive experience operating diverse businesses in London, Warsaw, Copenhagen, and Hong Kong. His current professional focus centers on early-stage investments in diabetes technology and advising emerging health businesses on capital raising and market strategies.
Craig Cooper is a distinguished Managing Director at Serpentine Ventures, a prominent venture capital firm known for its strategic investments in high-growth technology companies. In his pivotal role, Mr. Cooper is instrumental in identifying, evaluating, and nurturing promising startups that are poised to redefine their respective industries. He brings a wealth of experience and a keen eye for innovation to the firm's investment committee, actively shaping Serpentine Ventures' portfolio strategy.
Mr. Cooper's investment philosophy is centered on backing visionary entrepreneurs who are developing scalable solutions to complex problems. His primary focus areas include enterprise software, where he seeks out B2B SaaS platforms that enhance operational efficiency and drive digital transformation. He also has a strong interest in financial technology (fintech), particularly solutions that democratize access to financial services or streamline complex transactions. Furthermore, Mr. Cooper actively explores opportunities in digital health, supporting companies that leverage technology to improve patient outcomes, enhance healthcare delivery, and make wellness more accessible. He believes in a hands-on approach, working closely with portfolio company leadership to provide strategic guidance, facilitate market expansion, and navigate growth challenges.
Before joining Serpentine Ventures, Craig Cooper built a robust career marked by both entrepreneurial success and significant contributions to the investment landscape. His background includes experience as a founder of a successful tech startup, which provided him with invaluable firsthand insight into the challenges and triumphs of building a company from the ground up. This operational experience deeply informs his investment decisions, allowing him to empathize with founders and offer practical, actionable advice. He also held senior roles at other venture capital firms, where he honed his skills in deal sourcing, due diligence, and portfolio management across diverse technology sectors. His extensive network and deep industry knowledge are critical assets in sourcing proprietary deal flow and conducting thorough market analysis.
While specific individual investments are often confidential or part of broader fund activities, Mr. Cooper is known for his consistent track record in identifying companies with strong leadership, innovative technology, and significant market potential. He is committed to fostering long-term partnerships, providing not just capital but also strategic mentorship and access to Serpentine Ventures' extensive ecosystem of industry experts and resources. His dedication to empowering founders and driving technological advancement makes him a respected figure in the venture capital community.
Craig Cooper primarily invests in early-stage and growth-stage technology companies. His focus areas include enterprise software (B2B SaaS), financial technology (fintech), and digital health solutions.
Craig Cooper works as a Managing Director at Serpentine Ventures, a prominent venture capital firm that specializes in strategic investments in innovative technology companies.
